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Abstract Although relatively rare, melanoma accounts for
2 % of cancer diagnoses globally and accounts for about
1 % of all cancer deaths. Worldwide, the annual incidence of
melanoma is 272,000 cases which vary hugely, ranging from
Japan where it is incredibly infrequent, to Queensland,
Australia, where it is nearly 100 times higher. Based on epi-
demiology and laboratory studies, there is compelling evi-
dence suggesting that seaweed might be protective against
different types of cancers such as breast cancer in seaweed
consuming populations. By comparing countries where mel-
anoma is more common with countries where it is infrequent,
it is possible to construct a hypothesis for how consuming
brown seaweeds which may hold clues to the differences in
melanoma susceptibility between Japanese and Western na-
tions. Unlike in these other countries, where melanoma inci-
dence has increased dramatically over the last two decades, in
Japan, rates have remained remarkably low and stable. There
is limited evidence from clinical studies and animal models
that have used whole seaweed or isolated fractions from sea-
weed and measured changes in biomarkers. They have dem-
onstrated the effectiveness of seaweed at inhibiting melanoma
development and progression. In this review, the various re-
sults will be described. Although there are several effective
fractions, it is proposed that consuming whole seaweeds may
hold additional benefits that could be lost by consuming only
a single extract.
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Introduction
Melanoma is a relatively rare skin cancer in most of the coun-
tries of the world, accounting for about 2 % of all cancers, and
is responsible for 1 % of cancer deaths (Global Burden of
Disease Cancer 2015). It has been called the most aggressive
of all human cancers (Chin et al. 1998). Globally, an estimated
272,000 people are diagnosed with melanoma (Global Burden
of Disease Cancer 2015; World Health Organization 2016).
However, the incidence rates vary profoundly. In Japan, less
than one person per 100,000 is diagnosed with melanoma,
compared with Australia where current estimates for women
are 30/100,000 and for men are 40/100,000 (Queensland
Government 2015). Incidence rates have increased in many
countries, but not in Japan. Five-year survival rates for people
with melanoma depend on the stage of the disease at the time
of diagnosis. If treated early, there is a high rate of cure, but for
patients with late stage disease the success rate for therapies,
even the new immunotherapies, is about 15–20 % at 5 years
(American Cancer Society 2016). The development of treat-
ment resistance suggests that much remains to be understood
about how melanoma can remain dormant for years, avoiding
detection by the body’s immune system.
Melanoma has been reported in dogs, horses, pigs, birds,
and fish (Sweet et al. 2012;Williams et al. 2012). It also seems
to be part of our human heritage, although found most com-
monly among fair-skinned people with red hair. The oldest
record of melanoma dates back 2400 years ago to a mummy
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in Peru (Rebecca et al. 2012). About the same time in Greece,
Hippocrates described melanoma when he wrote about Bfatal
black tumors with metastasis^ (Chin et al. 1998). Generally,
the modern risk factors include fair skin, light-colored eyes,
red hair, inability to tan, intermittent exposure to strong sun-
light, especially blistering sunburns during childhood, and
family history of melanoma (World Health Organization
2016). In the last 100 years, the incidence of melanoma has
dramatically increased. This has been largely attributed to
changing attitudes towards having tanned skin. Coco
Chanel, a French fashion designer and cultural icon in the
1920s, popularized tanned skin as glamorous and it became
associated with having leisure time associated with wealth and
high social status (Erdmann et al. 2013). Generally, this image
of a healthy tan has persisted, particularly where people no
longer do outside manual labor, such as farming. The use of
tanning beds during cold dark winters continues despite recent
scientific evidence that their use increases the risk of develop-
ing melanoma (Lazovich et al. 2010). People in Asia have a
very different attitude towards tanning, and in general, avoid
sun exposure. Pale skin is preferred which can be seen in the
high demand for cosmetics that lighten skin (Quah et al.
2014).
Although much has been discovered about the genetic ba-
sis for melanoma, a cure for this cancer remains elusive. The
development of melanoma is a complex multistage process,
including a three-step initiation–promotion–progression sys-
tem mediated by several cellular, biochemical, and molecular
alterations (Rocha et al. 2007). Melanocytes are derived from
pluripotent neural crest stem cells and are responsible for mel-
anin production in specialized melanosomes. The pigment
produced leads to variations in color of skin, hair, feathers,
eyes, and scales in all vertebrates (Mort et al. 2015).
Melanocytes and their development is modulated by the KIT
(CD117) and microphthalmia-associated transcription factor
(MITF), and is involved in pigmentation and cell death, which
also plays a major role in the development and differentiation
of melanoma, migration of melanoma cells, and drug resis-
tance (Yajima et al. 2011; Lau et al. 2015). MITF is also
involved in regulating the amount of melanin produced by
melanocytes, thereby a prime target for treatments that aim
to lighten skin.
Sunburns may be a major factor in reducing melanoma
risk, however evidence has accumulated that diet may also
play a role. Melanoma risk is positively associated with obe-
sity as is a progression in diet-induced obesity (Chen et al.
2013; De Pergola and Silvestris 2013). People in Japan have
a fraction of the rate of obesity (3.2 %) as that reported in high
melanoma countries such as the USA (30.6 %), Australia
(21.7 %), and New Zealand (20.9 %) (Organization for
Cooperation and Development 2005). Diet choices have
fueled this increase in obesity, with larger portion sizes, higher
caloric intake, and increased intake of refined carbohydrates
and fats (Tokudome et al. 2000). However, studies of high-fat
diets have revealed contradictory data. A healthy low-fat
American diet seems to be protective, but a change from a
high-fat diet to a low-fat (<20 %) diet with increased fruit
and vegetables and grain was associated with an increased risk
of melanoma in a large study of nurses in the USA (Gamba
et al. 2013). A study in Australia, where the incidence of
melanoma is the highest in the world, likewise found sugges-
tive evidence that a high-fat diet was not associated with high
risk of melanoma and might even be protective (Granger et al.
2006).
The range of food eaten may be important. The Japanese
diet is noted for its wide assortment of vegetables, fish, shell-
fish, and drinking tea, and thus is similar to eating a traditional
Mediterranean diet, which is associated with about a 40 %
decrease in the risk of melanoma (Fortes et al. 2008). This
protective effect of a healthy diet was also observed in a sec-
ond study, although the specific effects of a Mediterranean
diet were limited to women under the age of 50 (Malagoli
et al. 2015). There have been no studies of diet and melanoma
in a Japanese population.
Several studies have previously evaluated the use of
specific diets to treat melanoma patients. One retrospec-
tive comparative analysis reported a six-fold increase in
five-year survival rates of melanoma patients treated with
the Gerson die t ( low sodium, h igh potass ium,
lactovegetarian diet that emphasizes fresh vegetables, fruit
juices, and vitamin supplements). However, the flawed
methodology limits the reliability of this study, but the
results are intriguing (Hildenbrand et al. 1995).
Due to the increasing incidence and elusive cure for mela-
noma, there has been increasing interest in natural compounds
that may hold promise (Chinembiri et al. 2014). Collins and
his colleagues have reviewed the potential uses of seaweed
extracts in a range of modern life diseases, but again, it does
not include the consumption of whole seaweeds in a whole
diet (Collins et al. 2016). Mohamed and colleagues have
reviewed the health benefits of seaweed as a sustainable func-
tional food for use in complementary and alternative therapies
(Mohamed et al. 2012).
Dietary seaweed is one of the many differences between
Western diets and a traditional Japanese diet. Given its unusu-
al distribution as a culinary favorite, it is easy to speculate that
including seaweed might make a difference. On average peo-
ple in Japan eat 14.3 g day−1 of seaweeds (Fukuda et al. 2006).
The actual amount of seaweed is difficult to estimate since it is
consumed as a hot water extract in soup, as a flavoring for
other foods (dashi), as a condiment, as a side dish, and occa-
sionally as part of an entrée. It is also commonly eaten as a
snack. Currently, dietary seaweed is increasing worldwide,
and it has been called the Bsuperfood^ by several prominent
chefs including the British chef Jamie Oliver in his most re-
cent book (Oliver 2015).
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Several difficulties are associated with the study of sea-
weeds against any human disease. First, there are about
30,000 seaweeds, although only five Konbu (Saccharina
japonica) , Wakame (Undaria pinnatif ida) , Hijiki
(Sargassum fusiforme), Nori (Pyropia tenera), and Mozuku
(Nemacystus decipiens) are commonly eaten in Japan (Fukuda
et al. 2006). Additionally, of the 267 studies using seaweeds in
cancer studies (indexed by PubMed, 5 August 2016), many
have used either a proprietary blend or rarely eaten seaweed,
perhaps in hopes of identifying a patentable extract.
Seaweed specific studies of inhibition of melanoma
Seaweeds have been studied in vitro and in vivo and several
extracts have shown efficacy at the inhibiting formation of
many forms of cancer. Although there have been more than
250 studies of seaweeds and cancer, few have focused on
melanoma (PubMed, 5 August, 2016). These studies are pre-
sented in Table 1. Melanoma cells are relatively easy to grow
in cell culture and in animal models. They readily metastasize
providing informative models for human melanoma.
However, the applicability of results from cell culture to
humans is tentative. Many of the natural defense mechanisms
of the complex human body play an important role in mitigat-
ing the effects of carcinogens and anti-carcinogens. Likewise,
the commonly used mouse melanoma model appears to be
good at studying the metastatic behavior of melanoma cells
but lacks the mechanisms of UV initiation and modulation of
the cancer process. It is therefore extremely attractive to ex-
amine population patterns of melanoma to discern information
about melanoma in human.
The best known of the anti-carcingenic seaweed extracts is
fucoidan. Several animal studies show fucoidan inhibits mel-
anoma in vitro and in vivo (Koyanagi et al. 2003; Ale et al.
2011a, 2011b; Croci et al. 2011; Vishchuk et al. 2012; Jin et al.
2014; Anisimova et al. 2015). These are presented in Table 1.
Cumashi et al. (2007) reviewed the many anti-inflammatory,
anti-coagulant, anti-angiogenic, and anti-adhesive activities of
fucoidans, and although varying slightly between the nine
species examined, generally concluded that fucoidans could
be helpful in improving health. A study supporting a role for
fucoidan in photoprotection was done by Anisimova et al.
(2015). They reported a 1.9-fold increase in cytotoxic activity
of spleen mononuclear leucocytes towards melanoma cells of
line B16 and concluded that one of the ways seaweed
fucoidan could influence antitumor activity was as an effector
of the innate immune system via CD11c integrins. Fucoidan
has been studied as both an anti-carcinogenic agent on its own
and as an adjunct to conventional therapies (Kwak 2014; Abu
et al. 2015; Atashrazm et al. 2015). A study of 70 elderly
subjects who were presumed to have age-related immune sup-
pression were randomized to either a daily dietary supplement
of 300 mg fucoidan or placebo given as an adjuvant to
standard seasonal influenza vaccine. There was a significant
enhancement of natural killer cell activity associated with
fucoidan but no increase in the group given the placebo
(Negishi et al. 2013). As the most effective treatments for late
stage melanoma involving immunotherapy that results in in-
creasing natural killer cell activity, this study is supportive of a
role for dietary fucoidan in melanoma treatments.
Several studies have reported that seaweed extracts
inhibited melanogenesis in mouse melanoma cells, and should
be considered for use in cosmetics for skin lightening (Kim
et al. 2013; Jin et al. 2014; Song et al. 2015). Since lighter skin
is a risk factor for susceptibility to melanoma, the activity of
fucoidan may not be helpful. However, Maruyama and col-
leagues reported that dietary Undaria sporophyll (mekabu)
was associated with significant suppression of the inflamma-
tory response to UVB exposure in mice (Maruyama et al.
2015). Perhaps it could be both an inhibitor of melanogenesis
and its pro-inflammatory reaction to UV light as well as a
photoprotector against the DNA damage that may cause
melanoma.
A study of a polysaccharide compound from Ascophyllum
sp., reported to be different in chemical composition from
fucoidan, has also been reported to have immune stimulating
activity against melanoma (Abu et al. 2015). Invasion and
migration of melanoma tumor cells were inhibited in vitro
and lung metastases were inhibited in vivo.
Dietary carotenoid intake has been associated with reduced
risk of melanoma (Millen et al. 2004). Fucoxanthin is the
major form of carotenoid found in brown seaweed chloro-
plasts, where it is part of the light-harvesting complex algae
use for photosynthesis and photoprotection. It accounts for
about 10 % of all natural carotenoids found in nature
(Miyashita et al. 2011). Animals cannot synthesize caroten-
oids but must obtain them from their diet. Fucoxanthin has an
unusual shape with an allenic bond found in only about 40 of
the more than 700 different naturally occurring carotenoids.
This may account for its wide range of biological activities
including thermagenesis, anti-obesity, anti inflammatory, and
anti carcinogenicity (Miyashita et al. 2011; Kumar et al. 2013;
Mikami and Hosokawa 2013). The data for specific anti-
melanoma activity include four studies demonstrating signif-
icant inhibition of melanoma in vitro and in vivo (Shimoda
et al. 2010; Chung et al. 2013; Imbs et al. 2013; Kim et al.
2013; Thomas and Kim 2013; Wang et al. 2014). Although
not specifically melanoma studies, several authors have re-
ported fucoxanthin (either orally or topically applied) reduced
UVB-induced skin inflammation in vitro and in vivo, and was
important in skin whitening (Lee et al. 2013).
Phlorotannins are phenolic compounds that are part of the
structural components of brown algae cell walls. They are
produced by seaweeds in response to high UV-B radiation
and grazing threats. They have been studied as possible
sources of sunscreens and other beneficial bioactive
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Table 1 Comparison of brown
seaweed extracts with activity
against melanoma





and adhesion in vitro
↓ lung metastases in vivo
↑ natural killer cell activity





↓ melanoma cells dose dependent
↑ apoptosis
↑ natural killer cell activity




Dose response ↓ melanoma
cell proliferation
Sargassum at lower dose;
Fucus at higher dose
Both ↑ apoptosis via ↑ caspase-3
Ale et al. 2011b
Chordaria
flagelliformis
↑innate immune system via
CD11c integrins
Anisimova et al. 2015
Alaria sp.
Saccharina japonica
↓ proliferation and colony formation;
Reproductively active tissue had
highest anti-melanoma activity
Vishchuk et al. 2012
Fucus vesiculosus As adjuvant tumor vaccine (with
chicken ovalbumin) induced Th1
and C-type lectin response,
protecting mice from melanoma
Jin et al. 2014
Fucus vesiculosus Fucoidan and oversulfated fucoidan
↓ melanoma growth and
angiogenesis in mice
Koyanagi, 2003
Saccharina latissima ↓ angiogenesis and tumor weight
↓ microvessel density
Croci et al. 2011
Fucoxanthin
Saccharina japonica ↓ expression and secretion of MMP-9
and glycoprotein CD44 and
↑CXCR4 (important in tumor
adhesion, extracellular invasion and
migration) in vitro;
↓ number tumors in vivo
Chung et al. 2013
Fucus evanescens ↓ growth human melanoma cells dose
dependent manner; 114 μM
effective concentration
Imbs et al. 2013
Ishige okamurae ↑ cell cycle arrest G(0)/G(1) phase;
↑ apoptosis and protein levels of Bcl-xL
↑ caspase-9, caspase-3, and PARP;
↓ growth of melanoma tumor
masses in mice





↓ suppressed skin mRNA expression
related to melanogenesis in
melanoma tumors in mice




↓ melanoma cell growth Wang et al. 2014
Galactolipids
Fucus evanescens ↓ growth human melanoma
cells dose dependent
manner; 104 μM effective
concentration
Imbs et al. 2013
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compounds (Li et al. 2011). In particular, phlorotannins have
been studied as tyrosinase inhibitors in melanoma cells al-
though the intent of the studies was to identify skin lightening
compounds in seaweeds, rather than to act against melanoma
tumors (Yoon et al. 2009; Kang et al. 2012).
Prebiotics have recently emerged as an important defense
against cancer. In humans, the intestine hosts about 1014 bac-
teria, or about ten times the number of human cells in an
average human (Gerritsen et al. 2011). The role for intestinal
bacteria in melanoma has recently emerged. In a study of two
groups of rats given a melanoma immunotherapy (pro-
grammed cell death-1 inhibitor) (PD-1 blocker), it was discov-
ered that rats with gastrointestinal populations of
Bifidobacterium longum had the same tumor control as those
rats administered the anti-PD-1 therapy that was being stud-
ied. Oral administration ofBifidobacterium to rats without this
intestinal bacteria was effective in inducing the same re-
sponse, and the combination of Bifidobacterium and anti-
PD-1 therapy almost abolished tumor growth (Sivan et al.
2015).
Dietary seaweeds have been found to have significant pre-
biotic effects that influence Bifidobacterium populations (de
Jesus et al. 2016). Wang reported that 2.5 % alginate supple-
mentation in rats increased Bifidobacterium by 13-fold com-
pared to the control group (Wang et al. 2006). An et al. (2013)
investigated the effects of two of the primary fermentable
seaweed polysaccharides on the relative abundance of micro-
biota in the caecal contents of rats fed a control (no fiber), a
2 % alginate diet, and a 2 % laminarin diet. They reported that
alginate was associated with a four-fold increase from 1 % in
the relative abundance of the bacteria in the Actinobacteria
phylum but a decrease to 0 % in the laminarin supplemented
the diet. Bifidobacterium, although a member of the
Actinobacteria phylum, was not specifically identified.
Interestingly, red seaweeds appear to have a similar effect in
increasing Bifidobacterium in animal studies using 2.5 %
Chondrus crispus (4.9-fold increase) in a rat study (Liu et al.
2015). A 1 % supplementation with Sarcodiotheca
gaudichaudii in a chicken study was associated with a 14-
fold increase (Kulshreshtha et al. 2014).
Alginic acid has been used for decades as an over the coun-
ter treatment for stomach hyperacidity (Malmud et al. 1979;
Holdt and Kraan 2011). The mode of action is to combine
with stomach acid to form a floating raft above the stomach
contents, thereby reducing stomach acid reflux. A study of
healthy male volunteers reported that a daily intake of 10 g
day−1 of alginate was associated with a significant increase in
fecal Bifidobacteria (Terada et al. 1995). In a general compar-
ison of fecal excretion of diverse bacteria, 106 healthy
Japanese volunteers had almost 20-fold higher excretion of
Bifidobacteria than people from 11 other countries studied
(Nishijima et al. 2016). These studies provide circumstantial
evidence for a possible role of dietary seaweed in enhancing
Bifidobacteria populations in people who consume brown
seaweeds, possibly contributing to protection against
melanoma.
It is also possible that eating brown seaweed increases
available fucose (Cao 2015). Protein fucosylation is key to
immune cell recognition, cell signaling, and general health,
and reduced cell surface fucosylation sites on melanoma cells
have been reported (Lau et al. 2015). Lau and his colleagues
reported that oral L-fucose (drinking water) fed to mice with
melanoma restored fucosylation in the melanoma tumors lead-
ing to about a 300 % increase in the number of intratumoral
natural killer cells and decreased metastases. In the same
study, the authors reviewed tumor tissue samples from 320
human melanoma patients. Higher expression of melanoma
cell surface protein fucosylation was associated with im-
proved overall survival and 34 % lower risk of metastases.
The exact mechanisms of action are still being investigated.
Bioavailability studies of brown seaweeds have focused on
fucoidan, rather than fucose (Irhimeh et al. 2005; Warttinger
et al. 2016). Fucose availability after eating raw seaweed is
negligible but if seaweed is digested by heat or enzymes, as is
likely with dietary seaweed, or gut microbes following inges-
tion, then free fucose would be made available. The fate of
fucose in the gut is to cross the membranes by diffusion or to
bind with certain cells (M) in Peyers’s patches and modulate
the immune system.
Clinical studies of brown seaweeds in healthy people
Accordingly, maybe another way to look at brown seaweeds
and melanoma is a general picture of what whole seaweed
does in healthy people and animals. We looked at healthy
humans in several clinical studies and have found that the
inclusion of 5 g day−1 brown seaweed (Alaria esculenta and
Undaria pinnatifia) was associated with changes in bio-
markers found in melanoma (Teas et al. 2009; Teas et al.
2011; Teas et al. 2013). Fifteen healthy postmenopausal wom-
en consumed 5 g day−1 placebo for a month, followed by 5 g
day−1 Undaria for a month, followed by 5 g day−1 of placebo
for a month. The most profound change was a significant
50 % reversible reduction in urinary urokinase receptor
(uPAR). In most cancers, patients with metastatic disease have
increasing excretion of uPAR and this is prognostic of a rap-
idly progressing disease. uPAR is an important factor in in-
flammation, differentiation, proliferation, detachment from
the extracellular matrix, and migration. Although we observed
this change in healthy women, they were mostly overweight
(average body mass index (BMI) of 30, which is the lower
limit for being obese). Adipose tissue has been reported to be
associated with an ongoing turnover of uPAR (Choe et al.
2016). However in terms of relevance to melanoma, in vitro
and in vivo studies of reducing uPAR on the surface of tumor
cells were associated with inducing a state of dormancy (Yu
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et al. 1997; Ossowski and Aguirre-Ghiso 2010; Noh et al.
2013). It remains to be seen if seaweed ingestion by melano-
ma patients could have a similar effect.
In a different study, we found a decrease in p-selectin plas-
ma concentration. In a small pilot study of eight people chal-
lenged with a high fat breakfast with and without 5 gUndaria,
we found that 4 h after eating that there was a significant
difference in p-selectin. It was increased with placebo and
decreased with seaweed (unpublished data, poster). For vari-
ous reasons, this study was not repeated in a larger sample
size, but a plethora of studies in animals have reported that
dietary seaweed and its extracts decrease p-selectin (Fitton
2011; Fitton et al. 2015). Many cancer cells including mela-
noma tumor cells bind to p-selectin in the process of moving
from one site to another. This effectively hides the tumor cells
from the body’s immune attack and from the sheer stress of
blood flow around them, increasing the likelihood of extrav-
asation into new tissue sites for metastases.
Limitations of studying of seaweeds
Several difficulties are associated with the study of seaweeds
against any human disease. First, there are about 30,000 sea-
weeds, although only five Konbu (Saccharina japonica),
Wakame (Undaria pinnatifida), Hijiki (Sargassum fusiforme),
Nori (Pyropia tenera), and Mozuku (Nemacystus decipiens)
are commonly eaten in Japan (Fukuda et al. 2006).
The structure and activity of various components of sea-
weed fractions have been widely studied. However, there are
few standard protocols for methods for extraction leading to
some lab-specific differences (Ale et al. 2011c; Jin et al. 2016;
Olivares-Molina and Fernández 2016). Other sources of var-
iability in studies of seaweed include pre-harvest variables
such as differences reported for the same kind of seaweed
harvested in different geographic environments, season, re-
productive status of the part of the plant used, part of the plant
used, age of the plant, as well as postharvest handling, such as
washing with seawater or fresh water, boiling, salting, shade
or sun drying, as well as storage (Vishchuk et al. 2012; Mak
et al. 2013; Ehrig and Alban 2015). Each of these factors has
been shown to impact biological activity.
Conclusions
In Japan, where most people consume seaweed daily, excep-
tionally low incidence and mortality rates of melanoma are
reported. These rates have remained stable over decades,
whereas in other developed countries rates have steadily in-
creased. Seaweeds contain many interesting compounds,
some of which have been studied specifically in conjunction
with melanoma and found to actively inhibit tumor initiation,
proliferation, and progression. However, due to the many
sources of variability in seaweed quality, it may be important
to eat a variety of whole seaweeds rather than to isolate indi-
vidual extracts. People in Japan eat a variety of whole sea-
weeds, not extracts. It seems likely this approach may be bet-
ter than attempting to find a specific extract or fraction to
commercially exploit as a Bmagic bullet^ at the expense of
possibly omitting an important component. Using amixture of
whole seaweeds, either as food or in a supplement rather than
an extract would also allow melanoma patients to add this
food to their diet without regulatory approval. The need for
dietary options for patients who have been told to Bgo home
and not worry^ is appealing. Dietary seaweed is already en-
couraged by the Ministry of Health in Japan as a healthy
everyday food. Further studies in melanoma patients are
warranted.
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